The Novel HLA ‐B*40:542 Allele Was Identified by Next‐Generation Sequencing
HLA · 2025
DOI: 10.1111/tan.70361 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2025. Verfasst von Qi Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China. Hauptthemen laut MEDLINE: Alleles, Exons, High-Throughput Nucleotide Sequencing, HLA-B40 Antigen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 4 Literaturangaben. Gefördert von: Science Research Foundation of Zhejiang Healthy Bureau.
Abstract (Originalsprache)
HLA‐B*40:542 differs from the HLA‐B*40:23 allele by two nucleotide substitutions in exon 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.
ORCID-Profile: Faming Zhu
Förderung
- Science Research Foundation of Zhejiang Healthy Bureau
Zitieren
APA
Li, Q., Pi, W., He, Y., Zhang, W., & Zhu, F. (2025). The Novel HLA ‐B*40:542 Allele Was Identified by Next‐Generation Sequencing. HLA. https://doi.org/10.1111/tan.70361
Vancouver
Li Q, Pi W, He Y, Zhang W, Zhu F. The Novel HLA ‐B*40:542 Allele Was Identified by Next‐Generation Sequencing. HLA. 2025. doi:10.1111/tan.70361
BibTeX
@article{Li2025,
author = {Li, Qi and Pi, Wenwen and He, Yizhen and Zhang, Wei and Zhu, Faming},
title = {The Novel HLA ‐B*40:542 Allele Was Identified by Next‐Generation Sequencing},
journal = {HLA},
year = {2025},
doi = {10.1111/tan.70361}
}
EUVIMED